These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 33990375)

  • 1. Mechanisms Driving Neutrophil-Induced T-cell Immunoparalysis in Ovarian Cancer.
    Emmons TR; Giridharan T; Singel KL; Khan ANH; Ricciuti J; Howard K; Silva-Del Toro SL; Debreceni IL; Aarts CEM; Brouwer MC; Suzuki S; Kuijpers TW; Jongerius I; Allen LH; Ferreira VP; Schubart A; Sellner H; Eder J; Holland SM; Ram S; Lederer JA; Eng KH; Moysich KB; Odunsi K; Yaffe MB; Zsiros E; Segal BH
    Cancer Immunol Res; 2021 Jul; 9(7):790-810. PubMed ID: 33990375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mature neutrophils suppress T cell immunity in ovarian cancer microenvironment.
    Singel KL; Emmons TR; Khan ANH; Mayor PC; Shen S; Wong JT; Morrell K; Eng KH; Mark J; Bankert RB; Matsuzaki J; Koya RC; Blom AM; McLeish KR; Qu J; Ram S; Moysich KB; Abrams SI; Odunsi K; Zsiros E; Segal BH
    JCI Insight; 2019 Mar; 4(5):. PubMed ID: 30730851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraperitoneal neutrophils activated by KRAS-induced ovarian cancer exert antitumor effects by modulating adaptive immunity.
    Yoshida M; Taguchi A; Kawana K; Ogishima J; Adachi K; Kawata A; Nakamura H; Sato M; Fujimoto A; Inoue T; Tomio K; Mori M; Nagamatsu T; Arimoto T; Koga K; Hiraike OW; Oda K; Kiyono T; Osuga Y; Fujii T
    Int J Oncol; 2018 Oct; 53(4):1580-1590. PubMed ID: 30066851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil and Granulocytic Myeloid-Derived Suppressor Cell-Mediated T Cell Suppression Significantly Contributes to Immune Dysregulation in Common Variable Immunodeficiency Disorders.
    Vlkova M; Chovancova Z; Nechvatalova J; Connelly AN; Davis MD; Slanina P; Travnickova L; Litzman M; Grymova T; Soucek P; Freiberger T; Litzman J; Hel Z
    J Immunol; 2019 Jan; 202(1):93-104. PubMed ID: 30487174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated neutrophils exert myeloid-derived suppressor cell activity damaging T cells beyond repair.
    Aarts CEM; Hiemstra IH; Béguin EP; Hoogendijk AJ; Bouchmal S; van Houdt M; Tool ATJ; Mul E; Jansen MH; Janssen H; van Alphen FPJ; de Boer JP; Zuur CL; Meijer AB; van den Berg TK; Kuijpers TW
    Blood Adv; 2019 Nov; 3(22):3562-3574. PubMed ID: 31738831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil Extracellular Traps Promote T Cell Exhaustion in the Tumor Microenvironment.
    Kaltenmeier C; Yazdani HO; Morder K; Geller DA; Simmons RL; Tohme S
    Front Immunol; 2021; 12():785222. PubMed ID: 34899751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formyl peptide enhances cancer immunotherapy by activating antitumoral neutrophils, and T cells.
    Sun H; Li S; Wang Q; Luo C; Zhong L; Wan G; Li Z; Zhao G; Bu X; Zeng M; Feng G
    Biomed Pharmacother; 2024 Jun; 175():116670. PubMed ID: 38692065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the lymphocyte metabolic switch by the oxidative burst of human neutrophils.
    Kramer PA; Prichard L; Chacko B; Ravi S; Overton ET; Heath SL; Darley-Usmar V
    Clin Sci (Lond); 2015 Sep; 129(6):489-504. PubMed ID: 25951298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Arginase 1 Liberates Potent T Cell Immunostimulatory Activity of Human Neutrophil Granulocytes.
    Vonwirth V; Bülbül Y; Werner A; Echchannaoui H; Windschmitt J; Habermeier A; Ioannidis S; Shin N; Conradi R; Bros M; Tenzer S; Theobald M; Closs EI; Munder M
    Front Immunol; 2020; 11():617699. PubMed ID: 33717053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting myeloid cells in the tumor microenvironment enhances vaccine efficacy in murine epithelial ovarian cancer.
    Khan AN; Kolomeyevskaya N; Singel KL; Grimm MJ; Moysich KB; Daudi S; Grzankowski KS; Lele S; Ylagan L; Webster GA; Abrams SI; Odunsi K; Segal BH
    Oncotarget; 2015 May; 6(13):11310-26. PubMed ID: 25888637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophils Lose the Capacity to Suppress T Cell Proliferation Upon Migration Towards Inflamed Joints in Juvenile Idiopathic Arthritis.
    Arve-Butler S; Mossberg A; Schmidt T; Welinder C; Yan H; Berthold E; Król P; Kahn R
    Front Immunol; 2021; 12():795260. PubMed ID: 35095871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Neutrophil Aging Contributes to T Cell Immune Suppression by PD-L1 and Arginase-1 in HIV-1 Treatment Naïve Patients.
    Liu K; Huang HH; Yang T; Jiao YM; Zhang C; Song JW; Zhang JY; Zhou CB; Yuan JH; Cao WJ; Mu XY; Zhou MJ; Li HJ; Shi M; Xu R; Wang FS
    Front Immunol; 2021; 12():670616. PubMed ID: 34489929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone Marrow Neutrophils of Multiple Myeloma Patients Exhibit Myeloid-Derived Suppressor Cell Activity.
    Petersson J; Askman S; Pettersson Å; Wichert S; Hellmark T; Johansson ÅCM; Hansson M
    J Immunol Res; 2021; 2021():6344344. PubMed ID: 34414242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hijacked Immune Cells in the Tumor Microenvironment: Molecular Mechanisms of Immunosuppression and Cues to Improve T Cell-Based Immunotherapy of Solid Tumors.
    Balta E; Wabnitz GH; Samstag Y
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloid-derived suppressor cells modulate immune responses independently of NADPH oxidase in the ovarian tumor microenvironment in mice.
    Godoy HE; Khan AN; Vethanayagam RR; Grimm MJ; Singel KL; Kolomeyevskaya N; Sexton KJ; Parameswaran A; Abrams SI; Odunsi K; Segal BH
    PLoS One; 2013; 8(7):e69631. PubMed ID: 23922763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactive Neutrophil Responses Dependent on the Receptor Tyrosine Kinase c-MET Limit Cancer Immunotherapy.
    Glodde N; Bald T; van den Boorn-Konijnenberg D; Nakamura K; O'Donnell JS; Szczepanski S; Brandes M; Eickhoff S; Das I; Shridhar N; Hinze D; Rogava M; van der Sluis TC; Ruotsalainen JJ; Gaffal E; Landsberg J; Ludwig KU; Wilhelm C; Riek-Burchardt M; Müller AJ; Gebhardt C; Scolyer RA; Long GV; Janzen V; Teng MWL; Kastenmüller W; Mazzone M; Smyth MJ; Tüting T; Hölzel M
    Immunity; 2017 Oct; 47(4):789-802.e9. PubMed ID: 29045907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA HOTTIP enhances IL-6 expression to potentiate immune escape of ovarian cancer cells by upregulating the expression of PD-L1 in neutrophils.
    Shang A; Wang W; Gu C; Chen C; Zeng B; Yang Y; Ji P; Sun J; Wu J; Lu W; Sun Z; Li D
    J Exp Clin Cancer Res; 2019 Sep; 38(1):411. PubMed ID: 31533774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil: A New Player in Metastatic Cancers.
    Wu M; Ma M; Tan Z; Zheng H; Liu X
    Front Immunol; 2020; 11():565165. PubMed ID: 33101283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined PD-1 blockade and GITR triggering induce a potent antitumor immunity in murine cancer models and synergizes with chemotherapeutic drugs.
    Lu L; Xu X; Zhang B; Zhang R; Ji H; Wang X
    J Transl Med; 2014 Feb; 12():36. PubMed ID: 24502656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus-stimulated neutrophils in the tumor microenvironment enhance T cell-mediated anti-tumor immunity.
    Chang CY; Tai JA; Li S; Nishikawa T; Kaneda Y
    Oncotarget; 2016 Jul; 7(27):42195-42207. PubMed ID: 27259252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.